These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 18308835

  • 1. Mass spectrometry is only one piece of the puzzle in clinical proteomics.
    McGuire JN, Overgaard J, Pociot F.
    Brief Funct Genomic Proteomic; 2008 Jan; 7(1):74-83. PubMed ID: 18308835
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Clinical perspectives of high-resolution mass spectrometry-based proteomics in neuroscience: exemplified in amyotrophic lateral sclerosis biomarker discovery research.
    Ekegren T, Hanrieder J, Bergquist J.
    J Mass Spectrom; 2008 May; 43(5):559-71. PubMed ID: 18416436
    [Abstract] [Full Text] [Related]

  • 5. Biomarker discovery from body fluids using mass spectrometry.
    Villar-Garea A, Griese M, Imhof A.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Apr 15; 849(1-2):105-14. PubMed ID: 17097359
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A novel approach using MALDI-TOF/TOF mass spectrometry and prestructured sample supports (AnchorChip Technology) for proteomic profiling and protein identification.
    Leung SM, Pitts RL.
    Methods Mol Biol; 2008 Apr 15; 441():57-70. PubMed ID: 18370311
    [Abstract] [Full Text] [Related]

  • 10. The application of SELDI-TOF mass spectrometry to mammalian cell culture.
    Woolley JF, Al-Rubeai M.
    Biotechnol Adv; 2009 Apr 15; 27(2):177-84. PubMed ID: 19049820
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. How to distinguish healthy from diseased? Classification strategy for mass spectrometry-based clinical proteomics.
    Hendriks MM, Smit S, Akkermans WL, Reijmers TH, Eilers PH, Hoefsloot HC, Rubingh CM, de Koster CG, Aerts JM, Smilde AK.
    Proteomics; 2007 Oct 15; 7(20):3672-80. PubMed ID: 17880000
    [Abstract] [Full Text] [Related]

  • 14. Perspectives for imaging mass spectrometry in the proteomics landscape.
    MacAleese L, Stauber J, Heeren RM.
    Proteomics; 2009 Feb 15; 9(4):819-34. PubMed ID: 19212956
    [Abstract] [Full Text] [Related]

  • 15. Sample preparation and fractionation for proteome analysis and cancer biomarker discovery by mass spectrometry.
    Ahmed FE.
    J Sep Sci; 2009 Mar 15; 32(5-6):771-98. PubMed ID: 19219839
    [Abstract] [Full Text] [Related]

  • 16. Serum peptidome profiling revealed platelet factor 4 as a potential discriminating Peptide associated with pancreatic cancer.
    Fiedler GM, Leichtle AB, Kase J, Baumann S, Ceglarek U, Felix K, Conrad T, Witzigmann H, Weimann A, Schütte C, Hauss J, Büchler M, Thiery J.
    Clin Cancer Res; 2009 Jun 01; 15(11):3812-9. PubMed ID: 19470732
    [Abstract] [Full Text] [Related]

  • 17. Industrialized MS-based proteomics in the search for circulating biomarkers.
    Migneault I, Hunter JM.
    Bioanalysis; 2009 Sep 01; 1(6):1149-63. PubMed ID: 21083081
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Data analysis of assorted serum peptidome profiles.
    Villanueva J, Philip J, DeNoyer L, Tempst P.
    Nat Protoc; 2007 Sep 01; 2(3):588-602. PubMed ID: 17406620
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.